Skip to main content
. 2025 Aug 21;61(8):1496. doi: 10.3390/medicina61081496
AD Autoimmune disease
AF Atrial fibrillation
APC Autologous platelets concentrates
A-PRF Advanced platelet-rich fibrin
AT-SVF Adipose-tissue stromal vascular fraction
BMP2 Bone morphogenetic protein 2
BPs Bisphosphonates
BRONJ Bisphosphonate-related osteonecrosis of the jaw
CGF Concentrated growth factor
CHX Chlorhexidine
CS Case Series
DM Diabetes
HCL Hypercholesterolemia
HF Heart Failure
HTA Hypertension
i-PRF Injectable platelet-rich fibrin
IV Intravenous
L-PRF Leukocyte-platelet rich fibrin
L-PRP Leukocyte- and platelet-rich plasma
MI Myocardial infarction
Min Minutes
MIU Million international units
MRONJ Medication-related osteonecrosis of the jaw
MTX Methotrexate
N.R. Not reported
ONJ Osteonecrosis of jaw
PDGF Platelet-derived growth factor
PO Per os
PPP Platelet-poor plasma
PRF Platelet-rich fibrin
PRGF Plasma rich in growth factors
PRP Platelet-rich plasma
RCT Randomized control trial
RD Rheumatoid disease
RF Renal Failure
rpm Rotations per minute
SC Subcutaneous
SVF Stromal vascular fraction